Optimal Therapy Is Often Combination Therapy for Disorders of Plasma Lipoproteins
|
|
|
|
|
|
|
Normalizing Lipid Levels Saves Lives |
|
All patients with angina (cardiac chest discomfort) or who have survived a heart attack (myocardial infarction), or who have undergone a heart blood vessel procedure (coronary artery bypass graft surgery, angioplasty, or stent placement) will benefit from intensive risk factor reduction including the correction of all detectable abnormalities in lipoproteins. Likewise, patients who have had thrombotic strokes or arteriosclerosis of the blood vessels serving the legs and persons at increased risk for any of these clinical problems will benefit from aggressive risk factor reduction. |
|
It has been shown repeatedly that men and women with blood vessel disease, or at high risk for a vascular event, will benefit from aggressive treatment of all lipoprotein abnormalities. This benefit includes a marked decrease in new clinical events and a reduction in the death rate. |
|
Practice History |
|
Intensive Risk Factor Reduction is available in a private practice setting and at the UCSF Lipid Clinic. Faculty members have been at the forefront of clinical and research activities in this field for more than 30 years. Drug treatment programs developed at UCSF are now standard care at most University Medical Center Lipid Clinics. In addition to providing clinical care, faculty members maintain active laboratory and clinical research programs. |
|
Private Practice. |
2299 Post Street Suite 203, San Francisco |
|
400 Parnassus Avenue, San Francisco |
|
|
Related Web Sites |
Calcification Within the Coronary Artery Is a Marker of Atherosclerosis |
|
|
|
Site Prepared by Philip H. Frost, M.D., updated 1-5-2005